Monday 21 September 2020
Home      All news      Contact us      India
oneindia.com - 2 month ago

Oxford COVID-19 vaccine: Panel recommends Serum Institute s name for phase 2, 3 human clinical trial

New Delhi, July 31: A subject expert committee on COVID-19 on Friday recommended to the country s drug regulator that permission be granted to Serum Institute of India (SII) for conducting the second and third phases of human clinical trials of the


Latest News
Hashtags:   

Oxford

 | 

COVID

 | 

vaccine

 | 

Panel

 | 

recommends

 | 

Serum

 | 

Institute

 | 

phase

 | 

human

 | 

clinical

 | 

trial

 | 

Sources